The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

Показать другие версии (1)

**Background:** There are sparse data addressing whether standard risk factors for febrile neutropenia (FN) are relevant in patients receiving myelosuppressive chemotherapy and primary prophylaxis for FN, which would have implications for variables to consider during real-world comparative analyses...

Полное описание

Библиографические подробности
Главные авторы:	Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang
Формат:	Статья
Язык:	English
Опубликовано:	Columbia Data Analytics, LLC 2021-06-01
Серии:	Journal of Health Economics and Outcomes Research
Online-ссылка:	https://jheor.scholasticahq.com/article/24564-the-impact-of-baseline-risk-factors-on-the-incidence-of-febrile-neutropenia-in-breast-cancer-patients-receiving-chemotherapy-with-pegfilgrastim-prophy.pdf

Схожие документы

The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis
по: Edward Li, и др.
Опубликовано: (2021-06-01)

Prophylaxis against febrile neutropenia with pegfilgrastim in Italy: a budget impact analysis
по: Giovanni Rosti, и др.
Опубликовано: (2011-09-01)

On-body injector pegfilgrastim for chemotherapy-induced neutropenia prophylaxis: Current Status
по: Ivo Abraham, и др.
Опубликовано: (2024-01-01)

Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy
по: Patrizia Berto, и др.
Опубликовано: (2022-02-01)

Incidence and Impact of Baseline Electrolyte Abnormalities in Patients Admitted with Chemotherapy Induced Febrile Neutropenia
по: Asim Jamal Shaikh, Samira Ahmed Bawany, Nehal Masood, Ausaf Ahmed Khan, Ahmed Nadeem Abbasi, Syed Najeeb Niamutullah, Adnan Zaidi, Salman Adil, Shiyam Kumar
Опубликовано: (2011-01-01)

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
по: Girma Tekle Gebremariam, и др.
Опубликовано: (2022-12-01)

An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer
по: Anbok Lee, и др.
Опубликовано: (2023-12-01)

Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis
по: Xia Zhu, и др.
Опубликовано: (2023-12-01)

Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
по: Shinya Tsuboi, и др.
Опубликовано: (2023-01-01)

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
по: Youngwoo Jeon, и др.
Опубликовано: (2023-03-01)

Prophylaxis and management of chemotherapy-induced febrile neutropenia: The role of myeloid growth factors
по: Dimitrijević Jelena, и др.
Опубликовано: (2022-01-01)

Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
по: Shinya Tsuboi, и др.
Опубликовано: (2023-04-01)

CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.
по: Luciana Teofili, и др.
Опубликовано: (2012-01-01)

CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.
по: Luciana Teofili, и др.
Опубликовано: (2012-10-01)

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy
по: Zsuzsanna Kahan, и др.
Опубликовано: (2019-02-01)

Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis
по: Zühre Kaya, и др.
Опубликовано: (2023-08-01)

NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
по: Pio Lopez, и др.
Опубликовано: (2008-03-01)

Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
по: Keita Miura, и др.
Опубликовано: (2024-02-01)

XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy
по: Topuzov E, и др.
Опубликовано: (2008-11-01)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
по: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
Опубликовано: (2020-10-01)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
по: Federica Cennamo, и др.
Опубликовано: (2021-11-01)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
по: Maria Bachlitzanaki, и др.
Опубликовано: (2023-10-01)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy
по: Mariana Antunes Faria Lima, и др.
Опубликовано: (2023-04-01)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
по: Paola Villafuerte-Gutierrez, и др.
Опубликовано: (2014-01-01)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
по: Doaa Naeem, и др.
Опубликовано: (2018-08-01)

Knowledge, attitude and practice towards chemotherapy-related neutropenia and febrile neutropenia among breast cancer patients
по: Yilin Chen, и др.
Опубликовано: (2024-10-01)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum]
по: Innocenti R, и др.
Опубликовано: (2019-02-01)

Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim
по: Jean Donadieu, и др.
Опубликовано: (2009-08-01)

Uso do dispositivo Pegfilgrastim OBI para prevenção de neutropenia: revisão de escopo
по: Vivian do Prado Martins, и др.
Опубликовано: (2023-08-01)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
по: Paola Villafuerte-Gutierrez, и др.
Опубликовано: (2019-01-01)

Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance—An Asian Perspective
по: Esther Shu-Ting Ng, и др.
Опубликовано: (2010-09-01)

Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy
по: Ngidi, S, и др.
Опубликовано: (2017)

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study
по: Patrick Wayne Cobb, и др.
Опубликовано: (2020-09-01)

Low albumin at the onset of febrile neutropenia predicts adverse outcome in pediatric febrile neutropenia
по: Manideepa Maji, и др.
Опубликовано: (2022-01-01)

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study
по: Agus Suryaman
Опубликовано: (2024-12-01)

Tratamiento ambulatorio del paciente con neutropenia febril Outpatient therapy in patients with febrile neutropenia
по: Andrés Londoño Gallo
Опубликовано: (2008-01-01)

Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer
по: Hongyuan Jia, и др.
Опубликовано: (2024-08-01)

Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
по: Sharifah Shakinah, и др.
Опубликовано: (2024-07-01)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
по: José C. Álvarez, и др.
Опубликовано: (2021-04-01)

Outcomes in 102 patients that present to the emergency department with chemotherapy-induced febrile neutropenia
по: Joo Han Lim, и др.
Опубликовано: (2011-08-01)